![]()
|
|
||||||||
J. Biol. Chem., Vol. 266, Issue 12, 7542-7548, 04, 1991
AE Karlsen, WY Fujimoto, P Rabinovitch, S Dube and A Lernmark
A rat islet tumor subclone, RIN-5AH-T2-B, was cultured with 2 mmol/liter of
the proliferation-arresting compound sodium butyrate (NaB). Insulin gene
expression and glucose-stimulated insulin release were analyzed and
compared with logarithmically proliferating and confluent control cells
cultured without NaB. Logarithmically proliferating control cells revealed
high insulin gene expression. In the presence of amino acids, these cells
showed a dose-dependent insulin response to glucose with a half-maximal and
maximal 6.5-fold stimulation by 0.8 and 5.6 mmol/liter D-glucose,
respectively. However, as the control cells approached growth arrest,
insulin gene expression subsided to below detectability, an occurrence that
is associated with decreased insulin release and accumulation of cells in
the G1 phase of the cell cycle. In contrast, NaB-arrested cells showed
continuous insulin gene expression throughout the experiment. Despite this,
insulin release in response to glucose was lost. NaB revealed a biphasic
effect on the cell-cycle: after an initial leaky G1 arrest during the first
24 h, the 5AH-B cells were arrested in G2 during the following 3 days.
These data suggest that insulin gene expression and glucose-stimulated
insulin release are affected by the cell cycle. These glucose-sensitive
RIN-5AH-T2-B cells may be useful in studies of insulin secretion and gene
regulation.
Effects of sodium butyrate on proliferation-dependent insulin gene expression and insulin release in glucose-sensitive RIN-5AH cells
R. H. Williams Laboratory, Department of Medicine, University of Washington, Seattle 98195.
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
A. E. Karlsen, S. G. Ronn, K. Lindberg, J. Johannesen, E. D. Galsgaard, F. Pociot, J. H. Nielsen, T. Mandrup-Poulsen, J. Nerup, and N. Billestrup Suppressor of cytokine signaling 3 (SOCS-3) protects beta -cells against interleukin-1beta - and interferon-gamma -mediated toxicity PNAS, September 26, 2001; (2001) 211445998. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. E. Karlsen, D. Pavlovic, K. Nielsen, J. Jensen, H. U. Andersen, F. Pociot, T. Mandrup-Poulsen, D. L. Eizirik, and J. Nerup Interferon-{gamma} Induces Interleukin-1 Converting Enzyme Expression in Pancreatic Islets by an Interferon Regulatory Factor-1-Dependent Mechanism J. Clin. Endocrinol. Metab., February 1, 2000; 85(2): 830 - 836. [Abstract] [Full Text] |
||||
![]() |
A. E. Karlsen, S. G. Ronn, K. Lindberg, J. Johannesen, E. D. Galsgaard, F. Pociot, J. H. Nielsen, T. Mandrup-Poulsen, J. Nerup, and N. Billestrup Suppressor of cytokine signaling 3 (SOCS-3) protects beta -cells against interleukin-1beta - and interferon-gamma -mediated toxicity PNAS, October 9, 2001; 98(21): 12191 - 12196. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |